How is the Neogenomics Inc. today?

The Neogenomics Inc. today is trading in the down by -4.78% at 7.96.

How has Neogenomics Inc. performed historically?

The Neogenomics Inc. is currently trading down -4.78% on an intraday basis in the past week the index rose 3.51%. The index has been down -42.77% in the past quarter and fell -49.07% in the past year. You can view this in the overview section.

What is Neogenomics Inc. Annual Revenue?

Neogenomics Inc. Annual Revenue rose 11.65%, in the last year to $660.57 M. Its sector's average revenue growth for the last fiscal year was 8.22%.

What is Neogenomics Inc. Annual Net Profit?

Neogenomics Inc. Annual Net Profit rose 10.51% in the last year to $78.73 M. Its sector's average net profit growth for the last fiscal year was 3.2%.

What is Neogenomics Inc. Price to Earning Ratio?

Neogenomics Inc. Price to Earning Ratio is -13.2, which is negative.

What is Neogenomics Inc. Stock Price?

Neogenomics Inc. Stock Price fell 49.07% and underperformed its sector by 52.6% in the past year.

What is Neogenomics Inc. Quarterly Revenue?

Neogenomics Inc. Quarterly Revenue rose 7.55% YoY to $168.04 M. Its sector's average revenue growth YoY for the quarter was 9.53%.

What is Neogenomics Inc. Quarterly Net profit?

Neogenomics Inc. Quarterly Net profit rose 4.21% YoY to $25.92 M. Its sector's average net profit growth YoY for the quarter was 47.62%.

What is Neogenomics Inc. Debt to Equity Ratio?

Neogenomics Inc. Debt to Equity Ratio of 0.67 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Neogenomics Inc. Return on Equity(ROE)?

Neogenomics Inc. Return on Equity(ROE) for the last financial year was -8.54%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Neogenomics Inc. Mutual Fund Holding?

Neogenomics Inc. Mutual Fund Holding decreased by 5.09% in the last quarter to 85.

What is Neogenomics Inc. Promoter Share Holding?

Neogenomics Inc. Promoter Share Holding increased by 0.06% in the most recent quarter to 0.65%.

What is Neogenomics Inc. Interest Coverage Ratio?

Neogenomics Inc. Interest Coverage Ratio is -11.19, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Neogenomics Inc. Institutional Holding?

Neogenomics Inc. Institutional Holding decreased by 1.14% in the last quarter to 95.6.

Neogenomics Inc. XNAS: NEO

Neogenomics Inc. Live Share Price Today, Share Analysis and Chart

Name: Neogenomics Inc.: Is Infosys Ltd. worth buying?
Item: Neogenomics Inc.
Rating: 1.278111125
Author: Trendlyne DVM scores

Weak Stock

about

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncolog...

7.96 -0.40 (-4.78%)

58.37% Fall from 52W High

1.3M XNAS Volume

XNAS 14 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Neogenomics Inc. is on 23 May 2025 for the purpose of NeoGenomics Inc Annual General Meeting for 2025 See details

Low Financial Strength

27.8 / 100

Expensive Valuation

17.3 / 100

Technically Bearish

29.4 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 40%

11 analysts

Neogenomics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Neogenomics Inc. Live Share Price Today, Share Analysis and Chart

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncolog...

58.37% Fall from 52W High

SWOT Analysis

Neogenomics Inc. Live Price Chart

Neogenomics Inc. FAQ

How is Neogenomics Inc. today?

Neogenomics Inc. today is trading in the red, and is down by -4.78% at 7.96.

How has Neogenomics Inc. performed historically?

Neogenomics Inc. is currently trading down -4.78% on an intraday basis. In the past week the stock rose 3.51%. stock has been down -42.77% in the past quarter and fell -49.07% in the past year. You can view this in the overview section.